At MO:RE, we empower life science researchers to generate reproducible, quality-controlled, and human-relevant human 3D cell models (NAM) that accelerate drug discovery, reduce reliance on animals, and prepare R&D pipelines for regulatory approval.

The MO:BOT is the first fully automated platform that standardizes NAM workflows from cell culture to drug screening with built-in quality control and regulatory-grade traceability.

Every step from organoid generation to downstream assays is tracked, documented, and auditable, creating comprehensive data packages that support IND submissions and establish a foundation for GMP compliance. Unlike fragmented solutions, MO:BOT delivers an integrated system for producing, testing, and validating human-relevant models at scale.